Cancer

Should we rename low risk cancers?

Should we rename low risk ("indolent") cancers in a bid to reduce anxiety and harm from unnecessary investigation and treatment? Experts debate the issue in The BMJ today.

Diseases, Conditions, Syndromes

Herd protection seen with 4-valent HPV vaccination

(HealthDay)—From 2006 to 2017, there was a decrease in 4-valent vaccine-type human papillomavirus (HPV) detection among vaccinated and unvaccinated women, according to a study published online Jan. 22 in Pediatrics.

page 3 from 5